300791.SZ
Sirio Pharma Co., Ltd.
SZSE · Consumer Defensive · C 制造业 · CN
CNY 16.98
+2.66%Margins
Gross margin
30.4%
EBITDA margin
5.8%
EBIT margin
-0.1%
Net margin
2.7%
FCF margin
0.9%
4.0%
Return on equity
2.1%
Return on assets
-0.1%
Return on invested capital
0.76x
Asset turnover
CNY 491.7M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026